1 / 4

Indian metabolic disorder therapeutics Market Size, Share, Analysis, Industry Report and Forecast - 2020-2026

Indian metabolic disorder therapeutics market is estimated to grow at a CAGR of 8.5% during the forecast period. Significant awareness regarding health and the rising prevalence of metabolic disorders are contributing to the growth of the market. In India, the prevalence of diabetes in adults was 8.9% in 2019 and the total incidences of diabetes in adults was 77 million in 2019.<br>

pooja99
Download Presentation

Indian metabolic disorder therapeutics Market Size, Share, Analysis, Industry Report and Forecast - 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Indian metabolic disorder therapeutics Market Size, Share, Analysis, Industry Report and Forecast - 2020-2026 Request a free sample of our report on Indian metabolic disorder therapeutics Market: https://www.omrglobal.com/request-sample/indian-metabolic-disorder-therapeutics- market ------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. Indian metabolic disorder therapeutics market is estimated to grow at a CAGR of 8.5% during the forecast period. Significant awareness regarding health and the rising prevalence of metabolic disorders are contributing to the growth of the market. In India, the prevalence of diabetes in adults was 8.9% in 2019 and the total incidences of diabetes in adults was 77 million in 2019. Diabetes interrupts metabolism function, which increases the need for medications for the treatment of the condition. These medications include Metformin (Glucophage, Glumetza, others), Thiazolidinediones (rosiglitazone (Avandia), and pioglitazone (Actos)), and others. Rosiglitazone (Avandia) is a thiazolidinediones group of medication which is intended for use as an adjunct to exercise and diet to improve glycemic control in adults with type 2 diabetes mellitus. It is a highly potent and selective agonist for the peroxisome proliferator-activated receptor- gamma (PPAR?)-responsive genes that participate in the regulation of fatty acid metabolism. Request a free sample of our report on Indian metabolic disorder therapeutics Market: https://www.omrglobal.com/request-sample/indian-metabolic-disorder-therapeutics- market Indian metabolic disorder therapeutics market is segmented based on type and disease. Based on type, the market is classified into drug therapy, gene therapy, cellular transplantation, enzyme replacement therapy, and others. In drug therapy, Metformin is a commonly used oral drug utilized to reduce blood glucose concentrations among patients with type-2 diabetes, primarily in patients who are obese and as well as those patients with normal renal function. Based on disease, the market is classified into obesity, diabetes, lysosomal storage disease, hypercholesterolemia, and others.

  3. A full report of Indian metabolic disorder therapeutics Market is available at: https://www.omrglobal.com/industry-reports/indian-metabolic-disorder-therapeutics- market Indian Metabolic Disorder Therapeutics Market Segmentation By Therapy •Drug Therapy •Gene Therapy •Cellular Transplantation •Enzyme Replacement Therapy •Others By Disease •Obesity •Diabetes •Lysosomal Storage Disease •Hypercholesterolemia •Others Company Profiles •AbbVie, Inc. •AstraZeneca plc •Biocon, Ltd. •Boehringer Ingelheim GmbH •Cipla, Inc.

  4. •Dr. Reddy's Laboratories Ltd. •Lupin, Ltd. •Novo Nordisk A/S •Ranbaxy Laboratories, Ltd. •Sun Pharmaceutical Industries, Ltd. For https://www.omrglobal.com/report-customization/indian-metabolic-disorder-therapeutics- market more customized data, request for report customization @ About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related